Plasma Anti-FXa Level as a Surrogate Marker of the Adequacy of Thromboprophylaxis in Critically Ill Patients: A Systematic Review

Thrombosis Research - United Kingdom
doi 10.1016/j.thromres.2015.12.016
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Elsevier BV


Related search